Protein-based nanoparticles: From preparation to encapsulation of active molecules

International Journal of Pharmaceutics

Volumn 522, Issue 1-2, 2017, Pages 172-197

  Tarhini, Mohamad ^a,b   Greige Gerges, Hélène ^b   Elaissari, Abdelhamid ^a  

^a UNIVERSITÉ LYON 1   (France)

^b LEBANESE UNIVERSITY   (Lebanon)

Author keywords

Active molecules; Encapsulation; Nanoparticles; Protein

Indexed keywords

AMOXICILLIN; DOXORUBICIN; GELATIN; HUMAN SERUM ALBUMIN; METHOTREXATE; NANOCARRIER; NANOPARTICLE; PACLITAXEL; PROTEIN; SODIUM CHLORIDE; VINBLASTINE SULFATE; DRUG CARRIER;

COACERVATION; CROSS LINKING; DISPERSION; DRUG RELEASE; NANOENCAPSULATION; PARTICLE SIZE; PHYSICAL CHEMISTRY; PRECIPITATION; PRIORITY JOURNAL; REVIEW; SPRAY DRYING; SURFACE PROPERTY; TEMPERATURE; THERMODYNAMICS; ZETA POTENTIAL; ANIMAL; CHEMISTRY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HUMAN;

ANIMALS; DRUG CARRIERS; DRUG COMPOUNDING; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; PROTEINS;

EID: 85015672988     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2017.01.067     Document Type: Review

References (73)

1. Arangoa, M.A., Campanero, M.A., Renedo, M.J., Ponchel, G., Irache, J.M., Gliadin nanoparticles as carriers for the oral administration of lipophilic drugs. Relationships between bioadhesion and pharmacokinetics. Pharm. Res. 18 (2001), 1521–1527.
2. Arangoa, M., Ponchel, G., Orecchioni, A., Renedo, M., Duchêne, D., Irache, J., Bioadhesive potential of gliadin nanoparticulate systems. Eur. J. Pharm. Sci. 11 (2000), 333–341.
3. Araujo, L., Löbenberg, R., Kreuter, J., Influence of the surfactant concentration on the body distribution of nanoparticles. J. Drug Target. 6 (1999), 373–385.
4. Avnir, Y., Turjeman, K., Tulchinsky, D., Sigal, A., Kizelsztein, P., Tzemach, D., Gabizon, A., Barenholz, Y., Fabrication principles and their contribution to the superior in vivo therapeutic efficacy of nano-liposomes remote loaded with glucocorticoids. PLoS One, 6, 2011, e25721.
5. Babapoor, S., Neef, T., Mittelholzer, C., Girshick, T., Garmendia, A., Shang, H., Khan, M.I., Burkhard, P., A novel vaccine using nanoparticle platform to present immunogenic m2e against avian influenza infection. Influenza Res. Treat. 2011 (2011), 1–12.
6. Bajpai, A.K., Choubey, J., Design of gelatin nanoparticles as swelling controlled delivery system for chloroquine phosphate. J. Mater. Sci. Mater. Med. 17 (2006), 345–358.
7. Batrakova, E.V., Bronich, T.K., Vetro, J.A., Kabanov, A.V., Polymer micelles as drug carriers. Nanoparticulates as Drug Carriers, 2006, 57–93.
8. Bochot, A., Fattal, E., Boutet, V., Deverre, J.R., Jeanny, J.C., Chacun, H., Couvreur, P., Intravitreal delivery of oligonucleotides by sterically stabilized liposomes. Invest. Ophthalmol. Vis. Sci. 43 (2002), 253–259.
9. Chen, M., Zhong, Z., Tan, W., Wang, S., Wang, Y., Recent advances in nanoparticle formulation of oleanolic acid. Chin. Med., 6, 2011, 20.
10. Couvreur, P., Puisieux, F., Nano- and microparticles for the delivery of polypeptides and proteins. Adv. Drug Deliv. Rev. 10 (1993), 141–162.
11. Dadparvar, M., Wagner, S., Wien, S., Kufleitner, J., Worek, F., von Briesen, H., Kreuter, J., HI 6 human serum albumin nanoparticles-Development and transport over an in vitro blood-brain barrier model. Toxicol. Lett. 206 (2011), 60–66.
12. Davidov-Pardo, G., Joye, I.J., Mcclements, D.J., Food-grade protein-based nanoparticles and microparticles for bioactive delivery: fabrication, characterization, and utilization. Advances in Protein Chemistry and Structural Biology, 2015, Elsevier Inc., 293–325.
13. Desai, N., Nanoparticle albumin bound (nab) technology: targeting tumors through the endothelial gp60 receptor and SPARC. Nanomed. Nanotechnol. Biol. Med., 3, 2016, 339.
14. Dreis, S., Rothweiler, F., Michaelis, M., Cinatl, J., Kreuter, J., Langer, K., Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles. Int. J. Pharm. 341 (2007), 207–214.
15. Duclairoir, C., Nakache, E., Marchais, H., Orecchioni, a.-M., Formation of gliadin nanoparticles: influence of the solubility parameter of the protein solvent. Colloid Polym. Sci. 276 (2014), 321–327.
16. Duclairoir, C., Orecchioni, a.M., Depraetere, P., Osterstock, F., Nakache, E., Evaluation of gliadins nanoparticles as drug delivery systems: a study of three different drugs. Int. J. Pharm. 253 (2003), 133–144.
17. Elzoghby, A.O., Elgohary, M.M., Kamel, N.M., Implications of protein- and peptide-based nanoparticles as potential vehicles for anticancer drugs. Protein and Peptide Nanoparticles for Drug Delivery, 1st ed., 2015, Elsevier Inc.
18. Elzoghby, A.O., Helmy, M.W., Samy, W.M., Elgindy, N.A., Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics. Int. J. Nanomed. 8 (2013), 1721–1732.
19. Esmaili, M., Ghaffari, S.M., Moosavi-Movahedi, Z., Atri, M.S., Sharifizadeh, A., Farhadi, M., Yousefi, R., Chobert, J.M., Haertlé, T., Moosavi-Movahedi, A.A., Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application. LWT - Food Sci. Technol. 44 (2011), 2166–2172.
20. Ezpeleta, I., Irache, J.M., Stainmesse, S., Chabenat, C., Popineau, Y., Orecchionp, A., Gliadin nanoparticles for the controlled release of all-trans-retinoic acid. Int. J. Pharm. 131 (1996), 191–200.
21. Fessi, H., Puisieux, F., Devissaguet, J.P., Ammoury, N., Benita, S., Nanocapsule formation by interfacial polymer deposition following solvent displacement. Int. J. Pharm. 55 (1989), 1–4.
22. Food and Drug Administration, ABRAXANE (paclitaxel). NDA, 2015, 021660.
23. Gaihre, B., Khil, M.S., Lee, D.R., Kim, H.Y., Gelatin-coated magnetic iron oxide nanoparticles as carrier system: drug loading and in vitro drug release study. Int. J. Pharm. 365 (2009), 180–189.
24. Gradishar, W.J., Albumin-bound paclitaxel: a next-generation taxane. Expert Opin. Pharmacother. 7 (2006), 1041–1053.
25. Gupta, A.K., Gupta, M., Yarwood, S.J., Curtis, A.S.G., Effect of cellular uptake of gelatin nanoparticles on adhesion, morphology and cytoskeleton organisation of human fibroblasts. J. Control. Release 95 (2004), 197–207.
26. Irache, J.M., Bergougnoux, L., Ezpeleta, I., Gueguen, J., Orecchioni, A.M., Optimization and in vitro stability of legumin nanoparticles obtained by a coacervation method. Int. J. Pharm. 126 (1995), 103–109.
27. Jahanshahi, M., Babaei, Z., Protein nanoparticle: a unique system as drug delivery vehicles. J. Biotechnol. 7 (2008), 4926–4934.
28. Jain, S.K., Gupta, Y., Jain, A., Saxena, A.R., Khare, P., Jain, A., Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery. Nanomedicine 4 (2008), 41–48.
29. Kaul, G., Amiji, M., Biodistribution and targeting potential of poly(ethylene glycol)-modified gelatin nanoparticles in subcutaneous murine tumor model. J. Drug Target. 12 (2004), 585–591.
30. Kim, T.H., Jiang, H.H., Youn, Y.S., Park, C.W., Tak, K.K., Lee, S., Kim, H., Jon, S., Chen, X., Lee, K.C., Preparation and characterization of water-soluble albumin-bound curcumin nanoparticles with improved antitumor activity. Int. J. Pharm. 403 (2011), 285–291.
31. Kundu, J., Chung, Y.Il, Kim, Y.H., Tae, G., Kundu, S.C., Silk fibroin nanoparticles for cellular uptake and control release. Int. J. Pharm. 388 (2010), 242–250.
32. Lammel, A.S., Hu, X., Park, S.H., Kaplan, D.L., Scheibel, T.R., Controlling silk fibroin particle features for drug delivery. Biomaterials 31 (2010), 4583–4591.
33. Langer, K., Anhorn, M.G., Steinhauser, I., Dreis, S., Celebi, D., Schrickel, N., Faust, S., Vogel, V., Human serum albumin (HSA) nanoparticles: reproducibility of preparation process and kinetics of enzymatic degradation. Int. J. Pharm. 347 (2008), 109–117.
34. Langer, K., Balthasar, S., Vogel, V., Dinauer, N., Von Briesen, H., Schubert, D., Optimization of the preparation process for human serum albumin (HSA) nanoparticles. Int. J. Pharm. 257 (2003), 169–180.
35. Lee, E.J., Khan, S.A., Park, J.K., Lim, K.H., Studies on the characteristics of drug-loaded gelatin nanoparticles prepared by nanoprecipitation. Bioprocess Biosyst. Eng. 35 (2012), 297–307.
36. Lee, E.J., Lee, N.K., Kim, I.S., Bioengineered protein-based nanocage for drug delivery. Adv. Drug Deliv. Rev. 106 (2015), 157–171.
37. Lee, G.Y., Park, K., Nam, J.H., Kim, S.Y., Byun, Y., Anti-tumor and anti-metastatic effects of gelatin-doxorubicin and PEGylated gelatin-doxorubicin nanoparticles in SCC7 bearing mice. J. Drug Target. 14 (2006), 707–716.
38. Lee, S.H., Heng, D., Ng, W.K., Chan, H.K., Tan, R.B.H., Nano spray drying: a novel method for preparing protein nanoparticles for protein therapy. Int. J. Pharm. 403 (2011), 192–200.
39. Leo, E., Angela Vandelli, M., Cameroni, R., Forni, F., Doxorubicin-loaded gelatin nanoparticles stabilized by glutaraldehyde: involvement of the drug in the cross-linking process. Int. J. Pharm. 155 (1997), 75–82.
40. Leroux, J.C., Cozens, R., Roesel, J.L., Galli, B., Kubel, F., Doelker, E., Gurny, R., Pharmacokinetics of a novel HIV-1 protease inhibitor incorporated into biodegradable or enteric nanoparticles following intravenous and oral administration to mice. J. Pharm. Sci. 84 (1995), 1387–1391.
41. López-Rubio, A., Lagaron, J.M., Whey protein capsules obtained through electrospraying for the encapsulation of bioactives. Innov. Food Sci. Emerg. Technol. 13 (2012), 200–206.
42. Mandal, B.B., Kundu, S.C., Self-assembled silk sericin/poloxamer nanoparticles as nanocarriers of hydrophobic and hydrophilic drugs for targeted delivery. Nanotechnology, 20, 2009, 355101.
43. Miladi, K., Ibraheem, D., Iqbal, M., Sfar, S., Fessi, H., Elaissari, A., Avicenne, R., Particles from preformed polymers as carriers for drug delivery. EXCLI J. 13 (2014), 28–57.
44. Mishra, V., Mahor, S., Rawat, A., Gupta, P.N., Dubey, P., Khatri, K., Vyas, S.P., Targeted brain delivery of AZT via transferrin anchored pegylated albumin nanoparticles. J. Drug Target. 14 (2006), 45–53.
45. Mohanraj, V.J., Chen, Y., Nanoparticles – a review. Trop. J. Pharm. Res. 5 (2006), 561–573.
46. Mohanraj, V.J., Chen, Y., Nanoparticles – a review. Trop. J. Pharm. Res. 5 (2006), 561–573.
47. Montero, A., Fossella, F., Hortobagyi, G., Valero, V., Docetaxel for treatment of solid tumours: a systematic review of clinical data. Lancet Oncol. 6 (2005), 229–239.
48. Müller, R.H., Mäder, K., Gohla, S., Solid lipid nanoparticles (SLN) for controlled drug delivery – a review of the state of the art. Eur. J. Pharm. Biopharm. 50 (2000), 161–177.
49. Nagavarma, B.V.N., Yadav, H.K.S., Ayaz, A., Vasudha, L.S., Shivakumar, H.G., Different techniques for preparation of polymeric nanoparticles – a review. Asian J. Pharm. Clin. Res. 5 (2012), 16–23.
50. Orive, G., Gascón, A.R., Hernández, R.M., Domínguez-Gil, A., Pedraz, J.L., Techniques: new approaches to the delivery of biopharmaceuticals. Trends Pharmacol. Sci. 25 (2004), 382–387.
51. Pan, K., Luo, Y., Gan, Y., Baek, S.J., Zhong, Q., pH-driven encapsulation of curcumin in self-assembled casein nanoparticles for enhanced dispersibility and bioactivity. Soft Matter 10 (2014), 6820–6830.
52. Panyam, J., Labhasetwar, V., Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv. Drug Deliv. Rev. 55 (2003), 329–347.
53. Pathak, Y., Thassu, D., Drug Delivery Nanoparticles Formulation and Characterization, Drugs and the Pharmaceutical Sciences. first edition, 2009.
54. Penalva, R., Esparza, I., Agüeros, M., Gonzalez-Navarro, C.J., Gonzalez-Ferrero, C., Irache, J.M., Casein nanoparticles as carriers for the oral delivery of folic acid. Food Hydrocoll. 44 (2015), 399–406.
55. Pimentel, T.A.P.F., Yan, Z., Jeffers, S.A., Holmes, K.V., Robert, S., Burkhard, P., Peptide nanoparticles as novel immunogens: design and ananlysis of a prototypic severe acute respiratory syndrome vaccine. Chem. Biol. 73 (2009), 53–61.
56. Pinto Reis, C., Neufeld, R.J., Ribeiro, A.J., Veiga, F., Nanoencapsulation. I. Methods for preparation of drug-loaded polymeric nanoparticles. Nanomed. Nanotechnol. Biol. Med. 2 (2006), 8–21.
57. Podaralla, S., Perumal, O., Preparation of zein nanoparticles by pH controlled nanoprecipitation. J. Biomed. Nanotechnol. 6 (2010), 312–317.
58. Rao, J.P., Geckeler, K.E., Polymer nanoparticles: preparation techniques and size-control parameters. Prog. Polym. Sci. 36 (2011), 887–913.
59. Rössler, B., Kreuter, J., Scherer, D., Collagen microparticles: preparation and properties. J. Microencapsul. 12 (1995), 49–57.
60. Sadeghi, R., Moosavi-Movahedi, A.A., Emam-jomeh, Z., Kalbasi, A., Razavi, S.H., Karimi, M., Kokini, J., The effect of different desolvating agents on BSA nanoparticle properties and encapsulation of curcumin. J. Nanoparticle Res., 2014, 16.
61. Sailaja, A.K., Amareshwar, P., Chakravarty, P., Different techniques used for the preparation of nanoparticles using. Int. J. Pharm. Pharm. Sci. 3 (2011), 45–50.
62. Schoonen, L., van Hest, J.C.M., Functionalization of protein-based nanocages for drug delivery applications. Nanoscale 6 (2014), 7124–7141.
63. Sebak, S., Mirzaei, M., Malhotra, M., Kulamarva, A., Prakash, S., Human serum albumin nanoparticles as an efficient noscapine drug delivery system for potential use in breast cancer: preparation and in vitro analysis. Int. J. Nanomed. 5 (2010), 525–532.
64. Torres-Giner, S., Martinez-Abad, A., Ocio, M.J., Lagaron, J.M., Stabilization of a nutraceutical omega-3 fatty acid by encapsulation in ultrathin electrosprayed zein prolamine. J. Food Sci. 75 (2010), N69–N79.
65. Umamaheshwari, R.B., Ramteke, S., Jain, N.K., Anti-Helicobacter pylori effect of mucoadhesive nanoparticles bearing amoxicillin in experimental gerbils model. AAPS PharmSciTech, 5, 2004, e32.
66. Vandervoort, J., Ludwig, A., Preparation and evaluation of drug-loaded gelatin nanoparticles for topical ophthalmic use. Eur. J. Pharm. Biopharm. 57 (2004), 251–261.
67. Varca, G.H.C., Queiroz, R.G., Lugão, A.B., Irradiation as an alternative route for protein crosslinking: cosolvent free BSA nanoparticles. Radiat. Phys. Chem. 124 (2016), 111–115.
68. Vauthier, C., Bouchemal, K., Methods for the preparation and manufacture of polymeric nanoparticles. Pharm. Res. 26 (2009), 1025–1058.
69. Wahome, N., Pfeiffer, T., Ambiel, I., Yang, Y., Keppler, O.T., Bosch, V., Burkhard, P., Conformation-specific display of 4E10 and 2F5 epitopes on self-assembling protein nanoparticles as a potential HIV v. Chem. Biol. Drug Des. 80 (2012), 349–357.
70. Wang, G., Uludag, H., Recent developments in nanoparticle-based drug delivery and targeting systems with emphasis on protein-based nanoparticles. Expert Opin. Drug Deliv. 5 (2008), 499–515.
71. Weber, C., Coester, C., Kreuter, J., Langer, K., Desolvation process and surface characterisation of protein nanoparticles. Int. J. Pharm. 194 (2000), 91–102.
72. Weber, C., Kreuter, J., Langer, K., Desolvation process and surface characteristics of HSA-nanoparticles. Int. J. Pharm. 196 (2000), 197–200.
73. Zhang, Z.-H., Wang, X.-P., Ayman, W.Y., Munyendo, W.L.L., Lv, H.-X., Zhou, J.-P., Studies on lactoferrin nanoparticles of gambogic acid for oral delivery. Drug Deliv. 20 (2013), 86–93.